Public consultation on the second EDCTP programme in 2014-2016
Update 17 October 2016: Deadline of Public Consultation extended till 15 November 2016.
A public consultation regarding ‘the implementation of the Second European and Developing Countries Clinical Trials Partnership Programme (EDCTP2) during the period 2014-2016’ was opened by the European Commission (EC) on 29 June 2016. It will close on 15 November 2016. The consultation is open to all. Contributions from stakeholders and experts active in the field of clinical trials are particularly invited. An analysis of results will be published in February 2017.
The views and opinions of stakeholders, experts active in the field and the wider public will contribute to the interim evaluation of the EDCTP2 programme. The interim evaluation is carried out by the EC with the assistance of independent experts.
Interim evaluations are part of the monitoring of the programmes the European Union decided to support. Decision Nr 556/2014/EU of the European Parliament and of the Council of 15 May 2014 on the participation of the European Union in EDCTP2 stipulates (art. 34) that the EC should conduct interim evaluations of the programme. The objective of this interim evaluation is “to assess the implementation of the EDCTP2 programme up to the present moment; to judge how recommendations from previous evaluations have been implemented; and to provide an outlook on what can be expected from EDCTP2 in the future”.
All information on the public consultation can be found on the website of the European Commission